Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Manitoba

$956,250.00

Control of B cell metabolism by the PI3K pathway: applications for autoimmunity

EF 2018-19

Résumé
The immune system is critical to human health. In order to develop vaccines and treatments for diseases where the immune system malfunctions (such as autoimmunity, inflammatory diseases or immunodeficiency), we need to better understand the fundamental mechanisms governing immune responses. Our research deals with the arm of the immune system responsible for producing antibodies, which are specialized proteins that bind to microorganisms and target them for destruction by the immune system. Antibodies are secreted into the blood and mucosal surfaces by cells called B lymphocytes. B lymphocytes express receptor proteins on their cell surface which allow them to sense the presence of foreign invaders, damaged cells and tissues, and other activated immune cells. Signals from these receptors trigger activation of individual B lymphocytes to divide, producing more copies of themselves, and mature into antibody secreting factories. Cell surface receptors deliver signals to the interior of the cell through signal transduction proteins which in turn activate enzymes that reprogram cellular metabolism to carry out either protective or damaging activities of these cells. Our research aims to define the molecular signaling pathways that regulate the activities of B lymphocytes during normal immune responses or abnormal autoimmune responses. Our work is identifying new molecular pathways that can be targeted to shut down B cells and treat autoimmune disease.
Programme
Project Grant
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
388836
Name
Marshall Aaron J
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Control of B cell metabolism by the PI3K pathway: applications for autoimmunity
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$956,250
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Autoantibody; B Lymphocyte; Kinase; Metabolism; Phosphatase; Phosphoinositide; Signal Transduction; Systemic Lupus Erythematosus
Abstract
The immune system is critical to human health. In order to develop vaccines and treatments for diseases where the immune system malfunctions (such as autoimmunity, inflammatory diseases or immunodeficiency), we need to better understand the fundamental mechanisms governing immune responses. Our research deals with the arm of the immune system responsible for producing antibodies, which are specialized proteins that bind to microorganisms and target them for destruction by the immune system. Antibodies are secreted into the blood and mucosal surfaces by cells called B lymphocytes. B lymphocytes express receptor proteins on their cell surface which allow them to sense the presence of foreign invaders, damaged cells and tissues, and other activated immune cells. Signals from these receptors trigger activation of individual B lymphocytes to divide, producing more copies of themselves, and mature into antibody secreting factories. Cell surface receptors deliver signals to the interior of the cell through signal transduction proteins which in turn activate enzymes that reprogram cellular metabolism to carry out either protective or damaging activities of these cells. Our research aims to define the molecular signaling pathways that regulate the activities of B lymphocytes during normal immune responses or abnormal autoimmune responses. Our work is identifying new molecular pathways that can be targeted to shut down B cells and treat autoimmune disease.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Marshall, Aaron J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $956,250~ $0~